Decentralized Trials: FDA Final Guidance Eliminates Need For Local Provider Activity Tracking

 
• By Sue Sutter
  
Health care provider
Local, qualified health care providers may perform certain activities in clinical trials with decentralized elements. • Source: Shutterstock

More from Clinical Trials

More from R&D